Louise Slaughter: “The world knows who is doing the big spending. We have the worst deficit we have ever seen. And as far as stepping up to…”

I am really excited about the opportunity to take a fresh look at a broader range of questions in pharmaceutical mergers than our traditional approach has taken.

We have all said so many times and we believe with all our hearts that the children in this country are our most important resource.

We will do incalculable harm if we did not keep that going, and we are better people than that.

Yes, so I think for a long time there has been a general sense in the antitrust world that vertical mergers are rarely bad, and in fact, may be mostly good.